Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Henlius Has First ‘China-Developed’ Biosimilar Accepted For EMA Review
Jun 25 2019
•
By
Penelope MacRae
Henlius is boasting the first China-developed biosimilar to be accepted for review by the EMA • Source: Shutterstock
More from Biosimilars
More from Products